Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Performance of low-risk criteria in direct oral challenge for children with suspected beta-lactam allergy
TCTR20210225004Phase 4Recruiting
- Sponsor
- Ramathibodi Hospital
- Start
- Feb 2021
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial in beta-lactam allergy and drug allergy, sponsored by Ramathibodi Hospital. Primary endpoints: Safety of direct oral beta-lactam challenge in low-risk children and Performance of low-risk criteria. Started Feb 2021; status: recruiting.
02
Conditions
beta-lactam allergydrug allergy
Beyond the preview
Go deeper on TCTR20210225004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210225004.